Drugs / islet body
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03728296 | Jan 2019 → Jan 2020 | type 1 diabetes mellitus | Allife Medical Science and Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | islet body | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03728296 ↗ |
| Modality | Cell therapy | “Transplanting islet bodies under the diaphragm” NCT03728296 ↗ |